Opens in a new tab

FRANCHISE RESALES

Buy a QC Kinetix Franchise

QC Kinetix is a regenerative medicine franchise founded in 2017 and headquartered in Charlotte, North Carolina. The brand operates a network of clinics across the United States providing non-surgical treatments for musculoskeletal conditions, including joint pain, chronic pain, and soft tissue injuries. Treatments are administered by licensed clinical staff and include biologic therapies such as platelet-rich plasma (PRP) and cellular therapy.

The business model is clinic-based and cash-pay: patients pay directly without insurance reimbursement. Franchisees employ a medical team that includes at least one licensed physician, clinical and sales staff, and a front desk function responsible for patient consultations and conversions. The franchise owner manages clinic operations, staffing, and local marketing rather than delivering treatments personally.

QC Kinetix has grown into one of the largest regenerative medicine franchises in North America, with more than 100 locations operating nationwide. The brand serves adults seeking alternatives to surgery, opioids, and long-term steroid use for conditions such as osteoarthritis, tendon injuries, and chronic joint pain.

Latest Resales

  • There are currently no QC Kinetix resales available

Why buy a QC Kinetix Franchise?

QC Kinetix operates within a growing healthcare category with increasing consumer interest in non-surgical treatment alternatives. The cash-pay model removes dependence on insurance networks, which simplifies billing and links revenue directly to local patient volume and conversion rather than reimbursement negotiations.

As one of the largest regenerative medicine franchises in North America, QC Kinetix provides national marketing infrastructure, call center support, and consumer visibility that an independent practitioner would take years to develop. Franchisees access the QCK Learning Hub and established clinical protocols, giving the operation a structured foundation. To buy a QC Kinetix franchise in resale means entering an existing clinic with a functioning medical team, established patients, and built-out operations already in place.

QC Kinetix Franchise Costs & Information

  • Minimum Qualifications

    • Initial Franchise Fee

      $55,000

    • Initial Investment

      $250,100 - $655,080

  • Royalty

    • Royalty Fee

      8%

  • Training & Support

    • 32 hours classroom training

    • Ongoing support

    • Marketing support

QC Kinetix – Additional  Information

  1. Training & Support

    QC Kinetix franchisees attend QCK University, an in-person program at corporate headquarters in Charlotte, NC. The clinical team receives hands-on in-lab training including cadaver-based injection and bone marrow technique practice. Front-desk and sales staff train virtually via the QCK Learning Hub. Ongoing support includes one-on-one coaching for the first six months, on-site clinic review visits, and marketing support with branded templates and local campaign guidance. Resale buyers should confirm what QCK University access and transfer training the franchisor provides to incoming owners and new clinical staff.

  2. Ideal Owner

    The ideal QC Kinetix franchisee is an operations-focused manager comfortable leading a multi-role team: a licensed physician, clinical staff, and a sales-driven front desk. A medical background is not required; entrepreneurs with strong business management experience and people leadership skills are well-suited. The owner drives local marketing, patient acquisition, and practice performance while clinical staff handle treatments. Comfort with premium patient expectations and experience managing employed teams in a service-led environment are key attributes.

  3. Recognition & Awards

    QC Kinetix has earned recognition for its growth in the regenerative medicine category. Franchise Times ranked the brand #1 on its Fast & Serious list (January 2024 issue) and #13 (January 2025), reflecting sustained sales and unit expansion. The brand appears in the Franchise Times Top 400 (2025, #307) and was named a Rising Star in Entrepreneur Magazine's 2023 Top New and Emerging Franchises. Inc. 5000 ranked QC Kinetix #62 among the fastest-growing US private companies in 2021.

  4. Industry / Market

    The North American regenerative medicine market is projected to grow from approximately $47 billion in 2025 to $230 billion by 2034 at a 19% compound annual growth rate, per Market Data Forecast. Demand is driven by aging populations, rising musculoskeletal disease rates, and patient interest in alternatives to surgery, opioids, and corticosteroid injections. Clinic revenue is directly tied to local patient volume and conversion rates rather than insurance billing. For resale buyers, territory demographics and local awareness of regenerative medicine are key evaluation factors.

Learn more about
how to own a QC Kinetix franchise resale

Please fill out the form below and a Franchise Flippers expert will be in touch with you shortly.

The Franchise Brand Index

This page is part of Franchise Flippers’ independent franchise Index, designed as an educational resource to help potential buyers explore the franchise resale market and compare brands.

Trademark & Affiliation Disclaimer

This website is an independent, informational resource. All trademarks, logos, and brand names displayed are the property of their respective owners and are used solely for identification and educational purposes. Their use does not imply any affiliation with, endorsement by, or sponsorship from the respective trademark holders.